Italian agency sets up access working group
This article was originally published in Scrip
AIFA, the Italian medicines agency, has set up a working group to study regional disparities in following its treatment guidelines. Professor Guido Rasi, the agency's director-general, has asked the group to begin its work with AIFA's guidance on treating glaucoma.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.